Wells Fargo’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
24,576
+2,510
| +11% | +$16.6K | ﹤0.01% | 4500 |
|
|
2025
Q1 | $202K | Sell |
22,066
-428
| -2% | -$3.92K | ﹤0.01% | 4256 |
|
|
2024
Q4 | $236K | Buy |
22,494
+5,459
| +32% | +$57.3K | ﹤0.01% | 4212 |
|
|
2024
Q3 | $204K | Buy |
17,035
+2,153
| +14% | +$25.7K | ﹤0.01% | 4182 |
|
|
2024
Q2 | $85.6K | Buy |
14,882
+14,626
| +5,713% | +$84.1K | ﹤0.01% | 4665 |
|
|
2024
Q1 | $1.33K | Buy |
256
+4
| +2% | +$21 | ﹤0.01% | 5700 |
|
|
2023
Q4 | $1.33K | Buy |
252
+14
| +6% | +$74 | ﹤0.01% | 5719 |
|
|
2023
Q3 | $785 | Buy |
238
+8
| +3% | +$26 | ﹤0.01% | 5877 |
|
|
2023
Q2 | $665 | Sell |
230
-5,448
| -96% | -$15.8K | ﹤0.01% | 6116 |
|
|
2023
Q1 | $6.08K | Buy |
5,678
+5,160
| +996% | +$5.52K | ﹤0.01% | 5680 |
|
|
2022
Q4 | $1.35K | Sell |
518
-296,927
| -100% | -$775K | ﹤0.01% | 5769 |
|
|
2022
Q3 | $2.08M | Sell |
297,445
-12,100
| -4% | -$84.7K | ﹤0.01% | 2556 |
|
|
2022
Q2 | $2.11M | Buy |
309,545
+291,963
| +1,661% | +$1.99M | ﹤0.01% | 2598 |
|
|
2022
Q1 | $248K | Sell |
17,582
-9,842
| -36% | -$139K | ﹤0.01% | 4568 |
|
|
2021
Q4 | $398K | Sell |
27,424
-158,205
| -85% | -$2.3M | ﹤0.01% | 4520 |
|
|
2021
Q3 | $2.63M | Buy |
185,629
+37,127
| +25% | +$526K | ﹤0.01% | 3267 |
|
|
2021
Q2 | $2.61M | Buy |
148,502
+146,094
| +6,067% | +$2.57M | ﹤0.01% | 3283 |
|
|
2021
Q1 | $37K | Buy |
+2,408
| New | +$37K | ﹤0.01% | 5591 |
|